Authors: HABERER LJ YIN Y PALMER JL KERSEY KE DEPEE SP

Citation: Lj. Haberer et al., PHARMACODYNAMIC EQUIVALENCE OF 4MG ONDANSETRON IV AND 4MG ONDANSETRONIM IN THE IPECAC-INDUCED EMESIS MODEL, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 20-20

Authors: KOCH KL BINGAMAN S XU L SUMMYLONG J HABERER LJ PRITCHARD JF

Citation: Kl. Koch et al., EFFECT OF ONDANSETRON ON MORPHINE-INDUCED NAUSEA, GASTRIC MYOELECTRICAL ACTIVITY AND PLASMA VASOPRESSIN LEVELS IN HEALTHY HUMANS, Gastroenterology, 110(4), 1996, pp. 696-696

Authors: KOCH KL BINGAMAN S XU L SUMMYLONG J HABERER LJ PRITCHARD JF

Citation: Kl. Koch et al., TITRATED MORPHINE-SULFATE INFUSIONS - A MODEL FOR INDUCING NAUSEA IN HUMANS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 26-26

Authors: HABERER LJ PALMER JL

Citation: Lj. Haberer et Jl. Palmer, EVALUATION OF THE EXPOSURE-RESPONSE RELATIONSHIP FOR ONDANSETRON IN PEDIATRIC CANCER-PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 156-156

Authors: HABERER LJ POLLACK GM

Citation: Lj. Haberer et Gm. Pollack, DISPOSITION AND PROTEIN-BINDING OF VALPROIC ACID IN THE DEVELOPING RAT, Drug metabolism and disposition, 22(1), 1994, pp. 113-119